Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

lcar-

lcar- is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 4
Pipeline programs 21
News articles 0
Drug details — lcar-
Class
—
Route
—
Patents
4
Programs
21
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

lcar- is an FDA-listed pharmaceutical active ingredient.

Key facts

INN lcar-

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. LCAR-B38M CAR-T Cell Phase 2 · Nanjing Legend Biotech · Multiple Myeloma
  2. LCAR-B38M CAR-T cell injection Phase 2 · Nanjing Legend Biotech · Refractory or Relapsed Multiple Myeloma
  3. Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy Phase 1 · Nanjing Legend Biotech · Refractory B Acute Lymphoblastic Leukemia
  4. Efficacy of LCAR-T2C CAR-T cells Phase 1 · Nanjing Legend Biotech · CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia
  5. Efficacy of LCAR-T2C CAR-T cells Phase 1 · Nanjing Legend Biotech · T Cell Lymphoma
  6. LCAR-AIO Cells Phase 1 · Chinese Academy of · Acute Lymphocytic Leukemia
  7. LCAR-AIO T cells Phase 1 · Nanjing Legend Biotech · Relapsed/Refractory Autoimmune Diseases
  8. LCAR-AIO T cells Phase 1 · Nanjing Legend Biotech · Systemic Lupus Erythematosus (SLE)

Related patents

Browse patents

  1. US 10071979

    Process of producing cycloalkylcarboxamido-indole compounds

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9035061

    Process for preparing a biphenyl-2-ylcarbamic acid

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9035072

    Process of producing cycloalkylcarboxamido-indole compounds

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8754225

    Process for preparing a biphenyl-2-ylcarbamic acid

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is lcar-?

lcar- is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.